Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Items 101–200 of 1,005
In vivo chemical reprogramming of astrocytes into neurons
Ma, Y., Xie, H., Du, X., Wang, L., Jin, X., Zhang, Q., Han, Y., Sun, S., Wang, L., Li, X., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00243-8 · Cited by 99
Self-citationBrouwer, M., Zhou, H., & Nadif Kasri, N. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9622-8 · Cited by 95
iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
Chromatin Accessibility Dynamics during Chemical Induction of Pluripotency
Cao, S., Yu, S., Li, D., Ye, J., Yang, X., Li, C., Wang, X., Mai, Y., Qin, Y., Wu, J., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.005 · Cited by 110
Self-citationThe Use of Stem Cell-Derived Organoids in Disease Modeling: An Update
Azar, J., Bahmad, H. F., Daher, D., Moubarak, M. M., Hadadeh, O., Monzer, A., Al Bitar, S., Jamal, M., Al-Sayegh, M., & Abou-Kheir, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147667 · Cited by 96
Adult Stem Cells and Diseases of Aging
Boyette, L., & Tuan, R. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3010088 · Cited by 108
“Recent studies have also focused on the screening of small molecules capable of reprogramming [191,192], with one group achieving successful reprogramming using a combination of seven compounds [193].”
BackgroundReprogramming cell fates by small molecules
Ma, X., Kong, L., & Zhu, S. (2017) · Protein & Cell · doi:10.1007/s13238-016-0362-6 · Cited by 108
Pluripotent Stem Cells from Domesticated Mammals
Ezashi, T., Yuan, Y., & Roberts, R. M. (2015) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-021815-111202 · Cited by 108
Zhang, C., Wang, X., Zhang, E., Yang, L., Yuan, H., Tu, W., Zhang, H., Yin, Z., Shen, W., Chen, X., et al. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.09.036 · Cited by 107
Chemical reprogramming and transdifferentiation
Xie, X., Fu, Y., & Liu, J. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.003 · Cited by 106
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
“In addition, an exciting alternative approach has been the elimination of classical reprogramming factors by exclusively using small-molecule compounds to reprogram mouse somatic cells (98).”
BackgroundAll Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation
Hu, K. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0620 · Cited by 105
Yilmaz, A., & Benvenisty, N. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.06.010 · Cited by 105
Next generation human skin constructs as advanced tools for drug development
Abaci, H., Guo, Z., Doucet, Y., Jacków, J., & Christiano, A. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217712690 · Cited by 104
Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells
Wuputra, K., Ku, C., Wu, D., Lin, Y., Saito, S., & Yokoyama, K. K. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01584-0 · Cited by 106
Do all roads lead to Oct4? The emerging concepts of induced pluripotency
Radzisheuskaya, A., & Silva, J. C. R. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.010 · Cited by 101
Kang, X., Yu, Q., Huang, Y., Song, B., Chen, Y., Gao, X., He, W., Sun, X., & Fan, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131128 · Cited by 86
Creation of a library of induced pluripotent stem cells from Parkinsonian patients
Holmqvist, S., Lehtonen, Š., Chumarina, M., Puttonen, K. A., Azevedo, C., Lebedeva, O., Ruponen, M., Oksanen, M., Djelloul, M., Collin, A., et al. (2016) · npj Parkinson's Disease · doi:10.1038/npjparkd.2016.9 · Cited by 90
Application of biomaterials to advance induced pluripotent stem cell research and therapy
Tong, Z., Solanki, A., Hamilos, A. E., Levy, O., Wen, K., Yin, X., & Karp, J. M. (2015) · The EMBO Journal · doi:10.15252/embj.201490756 · Cited by 97
Yang, J., Li, S., He, X.-B., Cheng, C., & Le, W. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0106-3 · Cited by 83
Direct Reprogramming of Fibroblasts via a Chemically Induced XEN-like State
Li, X., Liu, D., Ma, Y., Du, X., Jing, J., Wang, L., Xie, B., Sun, D. Q., Sun, S., Jin, X., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.05.019 · Cited by 94
Self-citationCD24 tracks divergent pluripotent states in mouse and human cells
Shakiba, N., White, C. A., Lipsitz, Y. Y., Yachie-Kinoshita, A., Tonge, P. D., Hussein, S. M. I., Puri, M. C., Elbaz, J., Morrissey-Scoot, J., Li, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms8329 · Cited by 85
Ye, J., Ge, J., Zhang, X., Cheng, L., Zhang, Z., He, S., Wang, Y., Lin, H., Yang, W., Liu, J., et al. (2015) · Cell Research · doi:10.1038/cr.2015.142 · Cited by 94
Self-citationChemical reprogramming for cell fate manipulation: Methods, applications, and perspectives
Wang, J., Sun, S., & Deng, H. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.08.001 · Cited by 91
Self-citationThe long and winding road of reprogramming-induced rejuvenation
Yücel, A. D., & Gladyshev, V. N. (2024) · Nature Communications · doi:10.1038/s41467-024-46020-5 · Cited by 91
Stem cells in tissues, organoids, and cancers
Wang, X. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03199-x · Cited by 76
Microfluidics for Neuronal Cell and Circuit Engineering
Habibey, R., Rojo Arias, J. E., Striebel, J., & Busskamp, V. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00212 · Cited by 85
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Gong, L., Yan, Q., Zhang, Y., Fang, X., Liu, B., & Guan, X. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0393-5 · Cited by 91
Borgohain, M. P., Haridhasapavalan, K. K., Dey, C., Adhikari, P., & Thummer, R. P. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9861-6 · Cited by 89
Materials control of the epigenetics underlying cell plasticity
Nemec, S. R., & Kilian, K. A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00238-z · Cited by 91
The use of small molecules in somatic-cell reprogramming
Alexander Joel Federation, Bradner, J. E., & Meissner, A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.09.011 · Cited by 89
Stem cells: a potential treatment option for kidney diseases
Liu, D., Cheng, F., Pan, S., & Liu, Z. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01751-2 · Cited by 88
Anti-Aging Strategies Based on Cellular Reprogramming
Ocampo, A., Reddy, P., & Belmonte, J. C. I. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.06.005 · Cited by 87
Wang, Y., Qin, J., Wang, S., Zhang, W., Duan, J., Zhang, J., Wang, X., Yan, F., Chang, M., Liu, X., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.06.006 · Cited by 87
Reprogramming with Small Molecules instead of Exogenous Transcription Factors
Lin, T., & Wu, S. (2015) · Stem Cells International · doi:10.1155/2015/794632 · Cited by 86
Genome-wide R-loop Landscapes during Cell Differentiation and Reprogramming
Yan, P., Liu, Z., Song, M., Wu, Z., Xu, W., Li, K., Ji, Q., Wang, S., Liu, X., Yan, K., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107870 · Cited by 79
Cell signalling pathways underlying induced pluripotent stem cell reprogramming
Hawkins, K., Joy, S., & McKay, T. R. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.620 · Cited by 85
Cancer: pathological nuclear reprogramming?
Goding, C. R., Pei, D., & Lü, X. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3781 · Cited by 84
Heman-Ackah, S. M., Bassett, A. R., & Wood, M. J. A. (2016) · Scientific Reports · doi:10.1038/srep28420 · Cited by 79
CRISPR-mediated genome editing and human diseases
Cai, L., Fisher, A. L., Huang, H., & Xie, Z. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.07.003 · Cited by 83
Small molecule–driven direct conversion of human pluripotent stem cells into functional osteoblasts
Kang, H., Shih, Y.-R. V., Nakasaki, M., Kabra, H., & Varghese, S. (2016) · Science Advances · doi:10.1126/sciadv.1600691 · Cited by 80
Trokovic, R., Weltner, J., Noisa, P., Raivio, T., & Otonkoski, T. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.06.001 · Cited by 83
Lunn, J. S., Sakowski, S. A., & Feldman, E. L. (2014) · Stem Cells · doi:10.1002/stem.1628 · Cited by 82
Tumorigenicity risk of iPSCs in vivo: nip it in the bud
Zhong, C., Liu, M., Pan, X., & Zhu, H. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac004 · Cited by 82
Chemical Conversion of Human Fibroblasts into Functional Schwann Cells
Thoma, E., Merkl, C., Heckel, T., Haab, R., Knoflach, F., Nowaczyk, C., Flint, N. A., Jagasia, R., Zoffmann, S., Truong, H., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.07.014 · Cited by 81
Transdifferentiation: a new promise for neurodegenerative diseases
Mollinari, C., Zhao, J., Lupacchini, L., Garaci, E., Merlo, D., & Pei, G. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0891-4 · Cited by 83
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
Brookhouser, N., Raman, S., Potts, C., & Brafman, D. A. (2017) · Cells · doi:10.3390/cells6010005 · Cited by 80
Reprogramming stem cells in regenerative medicine
Mao, J., Saiding, Q., Qian, S., Liu, Z., Zhao, B., Zhao, Q., Lu, B., Mao, X., Zhang, L., Zhang, Y., et al. (2022) · Smart Medicine · doi:10.1002/smmd.20220005 · Cited by 80
Hutchins, A. P., & Pei, D. (2015) · 中国科学通报:英文版 · doi:10.1007/s11434-015-0905-x · Cited by 79
Methods of induced pluripotent stem cells for clinical application
Seki, T., & Fukuda, K. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.116 · Cited by 78
Generation of pluripotent stem cells without the use of genetic material
Higuchi, A., Ling, Q., Kumar, S. S., Munusamy, M. A., Alarfaj, A. A., Chang, Y., Kao, S.-H., Lin, K.-C., Wang, H.-C., & Umezawa, A. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.132 · Cited by 78
Tan, Y., Ooi, S., & Wang, L. (2013) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x113086660068 · Cited by 78
Turinetto, V., Orlando, L., & Giachino, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091952 · Cited by 64
Immunological aspects of RPE cell transplantation
Sugita, S., Mandai, M., Kamao, H., & Takahashi, M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100950 · Cited by 77
“generated iPSC by using seven small molecules (Hou et al., 2013) to avoid using exogenous genetic factors.”
MethodReview: The future of cell therapies and brain repair: P arkinson's disease leads the way
Petit, G. H., Olsson, T. T., & Brundin, P. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12110 · Cited by 77
Induced pluripotent stem cell (iPSCs) and their application in immunotherapy
Jiang, Z., Han, Y., & Cao, X. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.62 · Cited by 79
Notch inhibition allows oncogene-independent generation of iPS cells
Ichida, J. K., TCW, J., Williams, L. A., Carter, A. C., Shi, Y., Moura, M. T., Ziller, M., Singh, S., Amabile, G., Bock, C., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1552 · Cited by 73
Choi, B., Park, K., Kim, J. ‐., Ko, K., Kim, J., Han, D. K., & Lee, S. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500273 · Cited by 76
Yan, Y., Li, Z., Kong, X., Jia, Z., Zuo, X., Gagea, M., Huang, S., Wei, D., & Xie, K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1691 · Cited by 76
NanoScript: A Nanoparticle-Based Artificial Transcription Factor for Effective Gene Regulation
Patel, S., Jung, D., Yin, P. T., Carlton, P. M., Yamamoto, M., Bando, T., Sugiyama, H., & Lee, K. (2014) · ACS Nano · doi:10.1021/nn501589f · Cited by 76
Jones, D. R., Wu, Z., Chauhan, D., Anderson, K. C., & Peng, J. (2014) · Analytical Chemistry · doi:10.1021/ac500476a · Cited by 75
Stem cell-based regenerative opportunities for the liver: State of the art and beyond
Tsolaki, E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12334 · Cited by 68
Functions and the Emerging Role of the Foetal Liver into Regenerative Medicine
Giancotti, A., Monti, M., Nevi, L., Safarikia, S., D’Ambrosio, V., Brunelli, R., Pajno, C., Corno, S., Donato, V. D., Musella, A., et al. (2019) · Cells · doi:10.3390/cells8080914 · Cited by 74
Bromodeoxyuridine promotes full-chemical induction of mouse pluripotent stem cells
Long, Y., Wang, M., Gu, H., & Xie, X. (2015) · Cell Research · doi:10.1038/cr.2015.96 · Cited by 69
Sakurai, K., Talukdar, I., Patil, V. S., Dang, J., Li, Z., Chang, K.-Y., Lu, C.-C., Delorme-Walker, V., DerMardirossian, C., Anderson, K., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.03.001 · Cited by 67
Dynamics of Telomere Rejuvenation during Chemical Induction to Pluripotent Stem Cells
Fu, H., Tian, C., Ye, X., Sheng, X., Wang, H., Liu, Y., & Liu, L. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.05.003 · Cited by 74
Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine
Basu, A., & Tiwari, V. K. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01131-4 · Cited by 72
Small molecules and small molecule drugs in regenerative medicine
Lu, B., & Atala, A. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.011 · Cited by 72
Development of stem cell-based therapy for Parkinson’s disease
Han, F., Baremberg, D., Gao, J., Duan, J., Lu, X., Zhang, N., & Chen, Q. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0039-8 · Cited by 72
Pesaresi, M., Sebastián-Pérez, R., & Cosma, M. P. (2018) · FEBS Journal · doi:10.1111/febs.14633 · Cited by 72
Feng, Q., Gao, H., Wen, H., Huang, H., Li, Q., Liang, M., Liu, Y., Dong, H., & Cao, X. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.06.046 · Cited by 73
Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00532 · Cited by 73
Goh, P. A., Caxaria, S., Casper, C., Rosales, C., Warner, T. T., Coffey, P. J., & Nathwani, A. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081622 · Cited by 67
Cellular Reprogramming of Human Peripheral Blood Cells
Zhang, X. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.001 · Cited by 71
Self-citationJung, D., Kim, W., & Williams, D. R. (2013) · ACS Chemical Biology · doi:10.1021/cb400754f · Cited by 69
Fang, J., Sia, J., Soto, J., Wang, P., Li, L. K., Hsueh, Y., Sun, R., Faull, K. F., Tidball, J. G., & Li, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00696-y · Cited by 69
Diecke, S., Lu, J., Lee, J., Termglinchan, V., Kooreman, N. G., Burridge, P. W., Ebert, A. D., Churko, J. M., Sharma, A., Kay, M. A., et al. (2015) · Scientific Reports · doi:10.1038/srep08081 · Cited by 62
Revilla, A., González, C., Iriondo, A., Fernández, B., Prieto, C., Marín, C., & Liste, I. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2021 · Cited by 59
Khan, M. (2024) · Polymers · doi:10.3390/polym16182629 · Cited by 67
Neural Stem Cells Differentiated From iPS Cells Spontaneously Regain Pluripotency
Choi, H. W., Kim, J. S., Choi, S., Hong, Y. J., Kim, M. J., Seo, H. G., & Tae, J. (2014) · Stem Cells · doi:10.1002/stem.1757 · Cited by 67
An Introduction to Stem Cell Biology and Tissue Engineering
Vishwakarma, A., Sharpe, P. T., Shi, S., & Ramalingam, M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397157-9.00001-1 · Cited by 67
Non-Viral Methods For Generating Integration-Free, Induced Pluripotent Stem Cells
Deng, X., Wang, H., Wang, T., Fang, X.-T., Zou, L., Li, Z., & Liu, C.-B. (2015) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140923101914 · Cited by 67
Self-citationSmall-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes
Tian, E., Sun, G., Sun, G., Chao, J., Ye, P., Warden, C., Riggs, A. D., & Shi, Y. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.042 · Cited by 62
Xie, B., Sun, D., Du, Y., Jia, J., Sun, S., Xu, J., Liu, Y., Xiang, C., Chen, S., Xie, H., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0196-x · Cited by 64
Self-citationHazim, R. A., Karumbayaram, S., Jiang, M., Dimashkie, A., Lopes, V. S., Li, D., Burgess, B. L., Vijayaraj, P., Alva-Ornelas, J. A., Zack, J. A., et al. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0652-9 · Cited by 66
“To circumvent the risks of genome integration, several nonintegrating methods are now being used to induce pluripotency in mammalian cells, including nonintegrating episomal vectors [8], delivery of RNA [9] and proteins [10], and use of small molecule compounds [11].”
Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming
Cipriano, A., Moqri, M., Maybury-Lewis, S. Y., Rogers-Hammond, R., de Jong, T. A., Parker, A., Rasouli, S., Schöler, H. R., Sinclair, D. A., & Sebastiano, V. (2023) · Nature Aging · doi:10.1038/s43587-023-00539-2 · Cited by 66
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
A practical guide to induced pluripotent stem cell research using patient samples
Santostefano, K. E., Hamazaki, T., Biel, N. M., Jin, S., Umezawa, A., & Terada, N. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.104 · Cited by 66
Giri, S., & Bader, A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.011 · Cited by 67
Srebp-1 Interacts with c-Myc to Enhance Somatic Cell Reprogramming
Wu, Y., Chen, K., Liu, X., Huang, L., Zhao, D., Li, L., Gao, M., Duan Qing, P. E. I., Wang, C., & Liu, X. (2015) · Stem Cells · doi:10.1002/stem.2209 · Cited by 66
Jung, J. P., Hu, D., Domian, I. J., & Ogle, B. M. (2015) · Scientific Reports · doi:10.1038/srep18705 · Cited by 66
Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells
Biswas, D., & Jiang, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020226 · Cited by 66
Li, D., Wang, L., Hou, J., Shen, Q., Chen, Q., Wang, X., Du, J., Cai, X., Shan, Y., Zhang, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.001 · Cited by 66
Self-citationChemical Modulation of Cell Fate in Stem Cell Therapeutics and Regenerative Medicine
Liu, K., Chen, Y., Xie, M., Li, K., & Ding, S. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.07.007 · Cited by 66
Self-citationGenome-Scale CRISPRa Screen Identifies Novel Factors for Cellular Reprogramming
Yang, J., Rajan, S. S., Friedrich, M., Lan, G., Zou, X., Ponstingl, H., Garyfallos, D. A., Liu, P., Bradley, A., & Metzakopian, E. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.02.010 · Cited by 66
Chemical approaches to cell reprogramming
Chen, Y., Liu, K., Tang, S., & Ding, S. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.09.006 · Cited by 65
Self-citationCuyàs, E., Gumuzio, J., Verdura, S., Brunet, J., Bosch‐Barrera, J., Martín-Castillo, B., Alarcón, T., Encinar, J. A., Martín, Á. G., & Menéndez, J. A. (2020) · Aging · doi:10.18632/aging.102887 · Cited by 65
Wang, B., Wu, L., Li, D., Liu, Y., Guo, J., Li, C., Yao, Y., Wang, Y., Zhao, G., Wang, X., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.068 · Cited by 64
Biological function of activation-induced cytidine deaminase (AID)
Chaudhuri, J., Evans, T., Kumar, R., & DiMenna, L. J. (2014) · Biomedical Journal · doi:10.4103/2319-4170.128734 · Cited by 64
Teratoma: from spontaneous tumors to the pluripotency/malignancy assay
Bulić‐Jakuš, F., Bojanac, A. K., Jurić‐Lekić, G., Vlahović, M., & Sinčić, N. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.219 · Cited by 64
Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
Qiao, Y., Agboola, O. S., Hu, X., Wu, Y., & Lei, L. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10042-5 · Cited by 64
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.